Recall of SLMD BP Acne Spot Treatment Due to Benzene Contamination
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Owen Biosciences Inc. is voluntarily recalling 2269 bottles of SLMD BP Acne Spot Treatment because of chemical contamination with benzene, affecting products distributed nationwide in the United States.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
Recall Article
What Happened
Owen Biosciences Inc. is initiating a recall due to chemical contamination with benzene in the product.
Which Products Are Affected
The affected product is SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles. A total of 2269 bottles are involved, specifically Lot# 2567200 with expiration date 8/1/26 and Lot# 2691600 with expiration date 10/30/2027. This recall applies to products distributed nationwide in the United States.
What You Should Do
Consumers should immediately stop using the affected product and contact Owen Biosciences Inc. for instructions, as the recall was initiated via letter notification.
Why This Matters
This recall addresses potential health risks from contaminated drugs, emphasizing the importance of product safety in the pharmaceutical industry.
Source
FDA Recall Notice: D-0454-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (891 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.